Glucagon-like peptide-1 7-36: a physiological incretin in man.
about
Glucagon-like peptide analogues for type 2 diabetes mellitusRegulation of glucose homeostasis by GLP-1Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1Identification, isolation, and characterization of daintain (allograft inflammatory factor 1), a macrophage polypeptide with effects on insulin secretion and abundantly present in the pancreas of prediabetic BB ratsTeneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetesThe role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic controlGastrointestinal hormones regulating appetiteMechanisms of action of glucagon-like peptide 1 in the pancreasPharmacokinetic and pharmacodynamic evaluation of linagliptin for the treatment of type 2 diabetes mellitus, with consideration of Asian patient populationsStimulation of incretin secreting cellsThe GLP-1 agonist, liraglutide, as a pharmacotherapy for obesityPancreatic regulation of glucose homeostasisMechanism Underlying the Weight Loss and Complications of Roux-en-Y Gastric Bypass. ReviewThe L-Cell in Nutritional Sensing and the Regulation of AppetiteIncretins and the intensivist: what are they and what does an intensivist need to know about them?GLP-1, the gut-brain, and brain-periphery axesDo we really know why diabetes remits after gastric bypass surgery?Physiology of proglucagon peptides: role of glucagon and GLP-1 in health and diseasecAMP-dependent mobilization of intracellular Ca2+ stores by activation of ryanodine receptors in pancreatic beta-cells. A Ca2+ signaling system stimulated by the insulinotropic hormone glucagon-like peptide-1-(7-37)Functional characterization of N-terminally GFP-tagged GLP-1 receptorGlucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic SuccessesThe physiological role of the brain GLP-1 system in stressEpigenetic regulation of the intestinal epitheliumPeripheral signals mediate the beneficial effects of gastric surgery in obesityEfficacy and tolerability of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitusRole of appetite-regulating peptides in the pathophysiology of addiction: implications for pharmacotherapyInhibition of dipeptidyl peptidase IV (DPP IV) is one of the mechanisms explaining the hypoglycemic effect of berberineSimple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapyThe anorectic effect of GLP-1 in rats is nutrient dependentThe glucagon-like peptide 1 analogue, exendin-4, attenuates the rewarding properties of psychostimulant drugs in micePostprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the ratThe glucagon-like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodentsGlucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and manEmerging role of dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetesActivation of murine pre-proglucagon-producing neurons reduces food intake and body weight.Efficacy and safety of dulaglutide in the treatment of type 2 diabetes: a comprehensive review of the dulaglutide clinical data focusing on the AWARD phase 3 clinical trial program.Oral glucose intake inhibits hypothalamic neuronal activity more effectively than glucose infusion.Expression of glucagon-like peptide-1 (GLP-1) receptor and the effect of GLP-1-(7-36) amide on insulin release by pancreatic islets during rat ontogenic development.Effects of glucose supplementation on gastric emptying, blood glucose homeostasis, and appetite in the elderly.Glucagon-like peptide-1 (GLP-1): a piece of the incretin puzzle.
P2860
Q24243685-F0CDCA1C-AAEA-4796-BDC0-7729757E23A3Q24563430-E05151FC-8FB1-4B74-A4FA-50FA6D545F0BQ24563957-CABC9AFF-2760-457B-943E-9A3ED91006BAQ24625957-699A0AD4-3F46-4AB1-8312-F94D87ACC478Q24628948-DDC5B48F-17FD-40A8-8F32-7F49FF1FD403Q24629879-18356DE4-7E9B-4F5A-8B06-E9CF3BFFE916Q24669951-4F617E01-8D97-4E4F-9E4E-8CE40D541846Q24683764-1E91E0A8-46CF-4072-9E08-7240DE47B886Q26749524-46D56E29-1834-4EE1-AA7D-480793F38AEEQ26765259-A97CD5B9-51E7-4DFC-8486-EFD1C449C8EAQ26765609-0AC798ED-B49C-4078-972A-3481E6EA7F77Q26766485-DC4B879C-416F-41F4-B56F-9FD73B10DFC4Q26780440-3BD8B8B3-64D3-41AF-9A14-646F5BF73A6EQ26799942-443FE097-F7A7-41DB-9EF4-53AB5D73FEDBQ26995464-24A14FAF-7915-4AFE-A963-533166E2A108Q27000749-7F71B33E-5560-4707-94DD-519878E31AC7Q27026687-15051CE6-6756-4B18-995F-82CBF0487D1CQ27027920-B3E16278-72C4-47F6-96D9-E4B8C4756465Q27863652-24B2E55B-6DEE-457B-A2FD-A8ECF215919EQ27865242-FBFDCA1A-66F9-43A5-94FF-67FB71F24DC0Q28067465-B9979E5C-C633-4A0C-8016-B30AEBA71DBEQ28077787-8AF2FE66-AB0C-42FB-9189-D27C3317F4FFQ28084849-10CF12B9-EECE-4785-9460-014A38CF2A72Q28088425-5ED79006-4F2B-49DC-8BBE-D7F6C2F1B99FQ28088578-CFEFC556-8DA3-4848-A8B7-7F2699888031Q28109507-9F6228BF-A7C1-4E2B-9042-B2C95F9FFD9DQ28253310-89199CA1-ADC0-4B27-B03A-BB35AE7C90E4Q28397980-D388142A-DE1C-440A-AF39-1FAD6B63EB35Q28484398-091424D0-4C4B-4D01-8339-F2355A38D0ADQ28534678-F9B64B35-076D-493E-A0E8-605B154FFF66Q28579516-BD48EE94-123B-47EE-9116-1B29EF9D6581Q28598004-3520C98B-F823-4F1C-BE66-7AA96D40D6E9Q28609252-FD3C5F70-E844-4520-A26A-3340C4B5AACAQ28762629-4C18E3A0-F206-4D6F-B3C7-588EDAEE52CBQ30352488-0947D09D-33A1-4D27-A4C0-1C59B9147D86Q31082841-D6D06078-BCAD-4E77-8CE9-3E1E238EDBB7Q31115560-7943ACEB-C967-406B-A58B-75556A0730CAQ31896896-2B8254F9-BD7C-4E8A-AEEF-4FD4C4E687DBQ32031898-4E933BCF-E600-4349-B072-9B6BA4975FD1Q33367023-F7C3BE4F-D0BC-42F2-9CA2-01D19C5B094B
P2860
Glucagon-like peptide-1 7-36: a physiological incretin in man.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
Glucagon-like peptide-1 7-36: a physiological incretin in man.
@en
Glucagon-like peptide-1 7-36: a physiological incretin in man.
@nl
type
label
Glucagon-like peptide-1 7-36: a physiological incretin in man.
@en
Glucagon-like peptide-1 7-36: a physiological incretin in man.
@nl
prefLabel
Glucagon-like peptide-1 7-36: a physiological incretin in man.
@en
Glucagon-like peptide-1 7-36: a physiological incretin in man.
@nl
P2093
P1433
P1476
Glucagon-like peptide-1 7-36: a physiological incretin in man.
@en
P2093
B Kreymann
G Williams
M A Ghatei
P304
P356
10.1016/S0140-6736(87)91194-9
P407
P577
1987-12-01T00:00:00Z